Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
3,4 SEK | +6,25% |
|
+3,66% | +10,75% |
Vakgebied
Aantal werknemers: 5
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Lars Minor
CEO | Chief Executive Officer | 53 | 01-01-21 |
Christoffer Tell
DFI | Director of Finance/CFO | 37 | 01-01-21 |
Director/Board Member | - | 01-08-22 | |
Sales & Marketing | 51 | 01-01-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Founder | 50 | 01-01-20 | |
Director/Board Member | 50 | 01-01-20 | |
Johan Strömqvist
BRD | Director/Board Member | 48 | 01-01-20 |
Anil Okay
BRD | Director/Board Member | 38 | 01-01-21 |
Director/Board Member | - | 01-08-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 19 521 154 | 9 005 041 ( 46,13 %) | 0 | 46,13 % |
Bedrijfsgegevens
Newbury Pharmaceuticals AB
Medicon Village Scheeletorget 1
223 81, Lund
+46 46 12 11 20
http://www.newburypharma.com![Adres Newbury Pharmaceuticals AB(NEWBRY)](https://cdn.zonebourse.com/static/address/131983565.png)
Sector
Chiffre d''affaires - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
+10,75% | 7,42 mln. | |
-10,31% | 8,31 mld. | |
+39,16% | 1,33 mld. | |
-9,54% | 343 mln. | |
+6,15% | 271 mln. | |
+9,44% | 223 mln. | |
-44,71% | 84,89 mln. | |
-29,36% | 67,77 mln. | |
+26,51% | 62,08 mln. |
- Beurs
- Aandelen
- Koers NEWBRY
- Onderneming Newbury Pharmaceuticals AB